Literatur
- 1
Neuhauser H K.
Epidemiology of vertigo.
Curr Opin Neurol.
2007;
20
40-46
- 2 Brandt T, Dieterich M, Strupp M. Vertigo – Leitsymptom Schwindel. 2. Auflage. Darmstadt;
Steinkopff 2010
- 3 Leigh R J, Zee D. The neurology of eye movements, 4 ed. Oxford, New York; Oxford
University Press 2006
- 4
Halmagyi G M, Curthoys I S.
A clinical sign of canal paresis.
Arch Neurol.
1988;
45
737-739
- 5
Zwergal A, Rettinger N, Frenzel C. et al .
A bucket of static vestibular function.
Neurology.
2009;
72
1689-1692
- 6
Karlberg M, Hall K, Quickert N. et al .
What inner ear diseases cause benign paroxysmal positional vertigo?.
Acta Oto Laryngol.
2000;
120
380-385
- 7
Brandt T, Steddin S.
Current view of the mechanism of benign paroxysmal positioning vertigo: cupulolithiasis
or canalolithiasis?.
J Vestib Res.
1993;
3
373-382
- 8
Brandt T, Steddin S, Daroff R B.
Therapy for benign paroxysmal positioning vertigo, revisited.
Neurology.
1994;
44
796-800
- 9
Semont A, Freyss G, Vitte E.
Curing the BPPV with a liberatory maneuver.
Adv Otorhinolaryngol.
1988;
42
290-293
- 10
Epley J M.
The canalith repositioning procedure: for treatment of benign paroxysmal positional
vertigo.
Otolaryngol Head Neck Surg.
1992;
107
399-404
- 11 Strupp M, Cnyrim C, Brandt T.
Vertigo and dizziness: treatment of benign paroxysmal positioning vertigo, vestibular
neuritis and Menière's disease. In: Candelise L, ed Evidence-Based Neurology – Management of Neurological Disorders. Oxford;
Blackwell Publishing 2007: 59-69
- 12
Brandt T, Huppert D, Hecht J. et al .
Benign paroxysmal positioning vertigo: a long-term follow-up (6–17 years) of 125 patients.
Acta Otolaryngol.
2006;
126
160-163
- 13
Minor L B, Schessel D A, Carey J P.
Menière's disease.
Curr Opin Neurol.
2004;
17
9-16
- 14
Sajjadi H, Paparella M M.
Menière's disease.
Lancet.
2008;
372
406-414
- 15
Strupp M, Huppert D, Frenzel C. et al .
Long-term prophylactic treatment of attacks of vertigo in Menière's disease – comparison
of a high with a low dosage of betahistine in an open trial.
Acta Otolaryngol (Stockh).
2008;
128
620-624
- 16
Theil D, Arbusow V, Derfuss T. et al .
Prevalence of HSV-1 LAT in human trigeminal, geniculate, and vestibular ganglia and
its implication for cranial nerve syndromes.
Brain Pathol.
2001;
11
408-413
- 17
Strupp M, Zingler V C, Arbusow V. et al .
Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.
N Engl J Med.
2004;
351
354-361
- 18
Strupp M, Arbusow V, Maag K P. et al .
Vestibular exercises improve central vestibulospinal compensation after vestibular
neuritis.
Neurology.
1998;
51
838-844
- 19
Neuhauser H, Leopold M, von Brevern M. et al .
The interrelations of migraine, vertigo, and migrainous vertigo.
Neurology.
2001;
56
436-441
- 20
Dieterich M, Brandt T.
Episodic vertigo related to migraine (90 cases): vestibular migraine?.
J Neurol.
1999;
246
883-892
- 21
Baier B, Winkenwerder E, Dieterich M.
„Vestibular migraine”: effects of prophylactic therapy with various drugs. A retrospective
study.
J Neurol.
2009;
256
436-442
- 22
Best C, Eckhardt-Henn A, Tschan R. et al .
Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results
of a prospective longitudinal study over one year.
J Neurol.
2009;
256
58-65
- 23
Eckhardt-Henn A, Best C, Bense S. et al .
Psychiatric comorbidity in different organic vertigo syndromes.
J Neurol.
2008;
255
420-428
- 24
Wagner J N, Glaser M, Brandt T. et al .
Downbeat nystagmus: aetiology and comorbidity in 117 patients.
J Neurol Neurosurg Psychiatry.
2008;
79
672-679
- 25
Kalla R, Deutschlander A, Hufner K. et al .
Detection of floccular hypometabolism in downbeat nystagmus by fMRI.
Neurology.
2006;
66
281-283
- 26
Strupp M, Schuler O, Krafczyk S. et al .
Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
Neurology.
2003;
61
165-170
- 27
Kalla R, Glasauer S, Buttner U. et al .
4-Aminopyridine restores vertical and horizontal neural integrator function in downbeat
nystagmus.
Brain.
2007;
130
2441-2451
- 28
Glasauer S, Kalla R, Buttner U. et al .
4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
J Neurol Neurosurg Psychiatry.
2005;
76
451-453
- 29
Strupp M, Kalla R, Dichgans M. et al .
Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
Neurology.
2004;
62
1623-1625
- 30
Brandt T, Dieterich M.
Phobischer Attacken-Schwankschwindel, ein neues Syndrom.
Münch Med Wochenschr.
1986;
128
247-250
- 31
Brandt T.
Phobic postural vertigo.
Neurology.
1996;
46
1515-1519
- 32
Brandt T, Huppert D, Dieterich M.
Phobic postural vertigo: a first follow-up.
J Neurol.
1994;
241
191-195
- 33
Kapfhammer H P, Mayer C, Hock U. et al .
Course of illness in phobic postural vertigo.
Acta Neurol Scand.
1997;
95
23-28
- 34
Pollak L, Klein C, Stryjer R. et al .
Phobic postural vertigo: a new proposed entity.
Isr Med Assoc J.
2003;
5
720-723
- 35
Huppert D, Strupp M, Rettinger N. et al .
Phobic postural vertigo – a long-term follow-up (5 to 15 years) of 106 patients.
J Neurol.
2005;
252
564-569
- 36
Holmberg J, Karlberg M, Harlacher U. et al .
Treatment of phobic postural vertigo. A controlled study of cognitive-behavioral therapy
and self-controlled desensitization.
J Neurol.
2006;
253
500-506
- 37
Holmberg J, Karlberg M, Harlacher U. et al .
One-year follow-up of cognitive behavioral therapy for phobic postural vertigo.
J Neurol.
2007;
254
II89-II92
Prof. Dr. Michael Strupp
Neurologische Klinik der LMU und Integriertes Forschungs- und Behandlungszentrum für
Schwindel, Gleichgewichts- und Okulomotorikstörungen (IFB LMU), Klinikum Großhadern
Marchioninistr. 15
81377 München
eMail: Michael.Strupp@med.uni-muenchen.de
